J. Vermehren

C. Sarrazin, J. Vermehren, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Treatment predictors of a sustained virologic response in hepatitis B and C.

C. Sarrazin, J. Vermehren, A. Kau, 2008, Journal of hepatology.

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers

A. Berger, A. Doehring, J. Lötsch, 2012, PloS one.

771 DECLINE OF DETECTABLE RESISTANCE MUTATIONS WITHIN THE HCV NS3 PROTEASE QUASISPECIES DURING LONG-TERM FOLLOW-UP AFTER TREATMENT WITH TELAPREVIR

S. Zeuzem, C. Sarrazin, J. Vermehren, 2010 .

Quadruple mutation GCAC1809-1812TTCT acts as a biomarker in healthy European HBV carriers

J. Trebicka, E. Hildt, E. Herrmann, 2020, JCI insight.

Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients

E. Hildt, S. Zeuzem, C. Sarrazin, 2018, The Journal of infectious diseases.

Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection

E. Hildt, S. Zeuzem, C. Sarrazin, 2018, Alimentary pharmacology & therapeutics.

Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.

P. Belperio, E. Herrmann, S. Zeuzem, 2018, The lancet. Gastroenterology & hepatology.

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.

K. Badenhoop, E. Herrmann, M. von Wagner, 2011, Journal of hepatology.

Vitamin D deficiency and a CYP27B1–1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

K. Badenhoop, E. Herrmann, S. Zeuzem, 2010 .

Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy.

M. Manns, F. Baldanti, F. Ceccherini‐Silberstein, 2020, Journal of hepatology.

Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection

T. Berg, S. Yerly, O. Kalinina, 2020, Journal of viral hepatitis.

Retreatment of Patients who Failed Daa-Combination Therapies: Real-World Experience from a Large Hepatitis C Resistance Database

U. Spengler, C. Berg, S. Zeuzem, 2016 .

Diagnostics in hepatitis C: The end of response-guided therapy?

B. Maasoumy, J. Vermehren, 2016, Journal of hepatology.

Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C.

C. Sarrazin, Ming‐Lung Yu, J. Vermehren, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The role of resistance in HCV treatment.

Christoph Sarrazin, C. Sarrazin, J. Vermehren, 2012, Best practice & research. Clinical gastroenterology.

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

R. Bartenschlager, E. Herrmann, S. Zeuzem, 2016, PloS one.

Role of telaprevir plasma levels for predicting response to antiviral therapy in patients with hepatitis C virus genotype 1 infection

N. Ferreirós, S. Zeuzem, C. Sarrazin, 2014, Scandinavian journal of gastroenterology.

Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir.

S. Zeuzem, C. Sarrazin, M. Welker, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis

M. Friedrich-Rust, E. Herrmann, S. Zeuzem, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Eva Herrmann, Christoph Sarrazin, Stefan Zeuzem, 2009, Radiology.

Hepatic sarcoidosis: Clinical characteristics and outcome

S. Zeuzem, J. Schattenberg, G. Rohde, 2021, JHEP reports : innovation in hepatology.

Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.

M. Imamura, K. Chayama, T. Liang, 2020, The Journal of clinical investigation.

Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in healthy non-addicted subjects

R. Deichmann, U. Nöth, J. Lötsch, 2017, European Journal of Clinical Pharmacology.

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus

A. Berger, B. Kronenberger, S. Zeuzem, 2015, Journal of viral hepatitis.

Capnography monitoring of non‐anesthesiologist provided sedation during percutaneous endoscopic gastrostomy placement: A prospective, controlled, randomized trial

M. Friedrich-Rust, S. Zeuzem, J. Bojunga, 2020, Journal of gastroenterology and hepatology.

Colon capsule endoscopy: current status and future directions.

J. Vermehren, J. Albert, A. Tal, 2014, World journal of gastroenterology.

Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras

A. Mangia, S. Zeuzem, C. Sarrazin, 2019, Journal of Clinical Microbiology.

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection

S. Zeuzem, C. Sarrazin, M. Welker, 2016, Alimentary pharmacology & therapeutics.

Efficacy and safety of direct‐acting antivirals for hepatitis C in the elderly: A systematic review and meta‐analysis

E. Herrmann, S. Zeuzem, J. Vermehren, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals

Christoph Sarrazin, Stefan Zeuzem, B. Kronenberger, 2018, Liver Cancer.

Regression of fibrosis and portal hypertension in HCV‐associated cirrhosis and sustained virologic response after interferon‐free antiviral therapy

M. Friedrich-Rust, E. Herrmann, S. Zeuzem, 2016, Journal of viral hepatitis.

Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.

T. Barth, M. Melter, J. Vermehren, 2015, Molecular and cellular probes.

Second-Generation Cobas AmpliPrep/Cobas TaqMan HCV Quantitative Test for Viral Load Monitoring: a Novel Dual-Probe Assay Design

C. Sarrazin, J. Vermehren, G. Heilek, 2012, Journal of Clinical Microbiology.

Synthese substituierter Ethenyldiazene

M. Hanack, J. Vermehren, 1989 .

New HCV Therapies and Liver Transplantation.

J. Vermehren, J. Werner, 2016, Transplantation.

Association of Alpha-1 Antitrypsin Pi*Z Allele Frequency and Progressive Liver Fibrosis in Two Chronic Hepatitis C Cohorts

C. Trautwein, A. Teumer, S. Zeuzem, 2022, Journal of clinical medicine.

Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix

R. Deichmann, J. Kaiser, U. Nöth, 2016, Neuropsychopharmacology.

Necessity and Risks of Arterial Blood Sampling in Healthy Volunteer Studies

A. Doehring, J. Lötsch, B. Oertel, 2012, Clinical Pharmacokinetics.

Risk factors for early and late procedure‐related adverse events in percutaneous endoscopic gastrostomy: A single center, retrospective study

M. Friedrich-Rust, E. Herrmann, S. Zeuzem, 2018, Journal of gastroenterology and hepatology.

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study

M. Manns, E. Paxinos, C. Sarrazin, 2017, Therapeutic advances in gastroenterology.

Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

M. Manns, S. Zeuzem, C. Sarrazin, 2020, Zeitschrift für Gastroenterologie.

Point Shear‐Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver‐Related Events in Patients With Chronic Viral Hepatitis

M. Friedrich-Rust, S. Zeuzem, C. Sarrazin, 2020, Hepatology communications.

Efficacy of Direct-acting Antivirals for Chronic Hepatitis C Virus Infection in People Who Inject Drugs or Receive Opioid Substitution Therapy: A Systematic Review and Meta-analysis.

E. Herrmann, S. Zeuzem, J. Vermehren, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.

J. Pawlotsky, M. Kowgier, C. Sarrazin, 2018, The lancet. Gastroenterology & hepatology.

Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.

A. Berger, S. Zeuzem, C. Sarrazin, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

High Prevalence of Anti-HCV Antibodies in Two Metropolitan Emergency Departments in Germany: A Prospective Screening Analysis of 28,809 Patients

B. Schlosser, T. Berg, N. Haas, 2012, PloS one.

Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection.

O. Weiland, S. Zeuzem, C. Sarrazin, 2014, Journal of hepatology.

Conversion From Sirolimus to Everolimus in Long‐Term Liver Graft Recipients

E. Herrmann, S. Zeuzem, C. Sarrazin, 2017, Journal of clinical pharmacology.

AFP ratio predicts HCC recurrence after liver transplantation

J. Trojan, W. Bechstein, E. Herrmann, 2020, PloS one.

Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers

J. Trojan, J. Marquardt, J. Vermehren, 2018, Journal of Cancer Research and Clinical Oncology.

Risk-guided strategy to prevent cytomegalovirus associated complications after liver transplantation

W. Bechstein, E. Herrmann, S. Zeuzem, 2018, Future Virology.

Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study.

T. Berg, J. Dufour, D. Semela, 2017, Journal of hepatology.

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

F. Greten, J. Trojan, S. Zeuzem, 2018, Zeitschrift für Gastroenterologie.

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

M. Friedrich-Rust, E. Herrmann, S. Zeuzem, 2012, European journal of radiology.

Liver transplantation for chronic hepatitis C virus infection in the United States 2002–2014: An analysis of the UNOS/OPTN registry

B. Graubard, K. McGlynn, S. Zeuzem, 2017, PloS one.

Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid Homeostasis

M. Friedrich-Rust, U. Mihm, E. Herrmann, 2020, Journal of clinical medicine.

Contrast‐Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta‐analysis

Eva Herrmann, Stefan Zeuzem, Mireen Friedrich-Rust, 2013, Liver international : official journal of the International Association for the Study of the Liver.

miRNA-26b Downregulation in Peripheral Blood Mononuclear Cells of Patients with Hepatitis C Associated Lymphomas is Restored by Successful Interferon-Free Antiviral Therapy

M. Hansmann, S. Zeuzem, J. Vermehren, 2019, Antiviral therapy.

705 CONTRAST-ENHANCED ULTRASOUND FOR THE DIFFERENTIATION OF BENIGN AND MALIGNANT FOCAL LIVER LESIONS: A META-ANALYSIS AND SYSTEMATIC REVIEW

M. Friedrich-Rust, E. Herrmann, S. Zeuzem, 2012 .

High sustained virologic response rates in hepatitis C virus genotype 3 patients with and without cirrhosis treated with daclatasvir/sofosbuvir or velpatasvir/sofosbuvir ± ribavirin according to baseline resistance analysis

S. Zeuzem, C. Sarrazin, J. Vermehren, 2017 .

Efficacy of Treatment Using Direct Acting Antiviral Drugs (DAAS) in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma – Real Life Data

S. Zeuzem, C. Sarrazin, M. Welker, 2016 .

Non‐invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)‐associated liver disease and sustained virologic response (SVR): 3 years follow‐up of a prospective longitudinal study

M. Friedrich-Rust, J. Trebicka, E. Herrmann, 2021, Journal of viral hepatitis.

The efficacy and safety of direct acting antiviral treatment and clinical significance of drug–drug interactions in elderly patients with chronic hepatitis C virus infection

S. Zeuzem, C. Sarrazin, M. Welker, 2016, Alimentary pharmacology & therapeutics.